三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
KRASG12C全球竞争格局
KRASG12C全球竞争格局
竞争格局
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:206KB
图片尺寸:2349*1010
同报告图片
/
4
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
所属报告:
中国生物制药(1177.HK)-港股公司研究报告:传统Pharma龙头加速创新转型拓展全球布局-250922(46页).pdf
打包全文图表
相关数据
KRASG12C一线治疗NSCLC竞争格局(截至2026-6-25)
收藏
竞争格局
2026-07-01
原图定位
查看详情
全球KRASG12C突变的NSCLC发病人数
收藏
行业数据
2026-07-01
原图定位
查看详情
中国KRASG12C突变的NSCLC发病人数
收藏
行业数据
2026-07-01
原图定位
查看详情
图表11FDA获批KRASG12C抑制剂的全球销售额(百万美元)
收藏
行业数据
2026-02-25
原图定位
查看详情
全球在研的部分KRASG12C管线
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
收藏
行业数据
2026-01-07
原图定位
查看详情
2021-2033E全球KRASG12C抑制剂市场规模(百万美元)
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
收藏
市场规模
2026-01-07
原图定位
查看详情
图表13全球获批5款KRASG12C抑制剂
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
收藏
行业数据
2025-11-21
原图定位
查看详情
KRASG12C相对另外两类突变,在美国患病人
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
收藏
行业数据
2025-10-10
原图定位
查看详情
美国KRASG12C两大分子的商业竞争,BMS
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
收藏
行业数据
2025-10-10
原图定位
查看详情
格索雷塞疗效与安全性优于此前FDA获批的其他KRASG12C抑制剂
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
收藏
行业数据
2025-09-24
原图定位
查看详情
格索雷塞疗效与安全性优于此前FDA获批的其他KRASG12C抑制剂
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
收藏
行业数据
2025-09-24
原图定位
查看详情
KRASG12C全球竞争格局
PHRhYmxlPgogICAgPHRoZWFkPgogICAgICAgIDx0cj4KICAgICAgICAgICAgYGBgaHRtbAo8dGg+6I2v5ZOB5ZCN56ewPC90aD4KICAgICAgICAgICAgPHRoPueglOWPkeWFrOWPuDwvdGg+CiAgICAgICAgICAgIDx0aD7lhajnkIPmnIDpq5jnoJTlj5HpmLbmrrU8L3RoPgogICAgICAgICAgICA8dGg+5Lit5Zu95pyA6auY56CU5Y+R6Zi25q61PC90aD4KICAgICAgICAgICAgPHRoPuS4reWbveacgOmrmOeglOWPkemYtuauteaXtumXtDwvdGg+CiAgICAgICAgPC90cj4KICAgIDwvdGhlYWQ+CiAgICA8dGJvZHk+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5oiI5p2l6Zu35aGePC90ZD4KICAgICAgICAgICAgPHRkPuWKoOenkeaAnS/oib7lipvmlq88L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPuaJueWHhuS4iuW4gjwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDI1LzUvMjA8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5qC857Si6Zu35aGePC90ZD4KICAgICAgICAgICAgPHRkPuebiuaWueeUn+eJqS/mraPlpKflpKnmmbQ8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPuaJueWHhuS4iuW4gjwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDI0LzExLzU8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5rCf5rO96Zu35aGePC90ZD4KICAgICAgICAgICAgPHRkPuWKsuaWueWMu+iNry/kv6Hovr7nlJ/niak8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPuaJueWHhuS4iuW4gjwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDI0LzgvMjA8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+6Zi/6L6+5qC85ouJ6KW/5biDPC90ZD4KICAgICAgICAgICAgPHRkPkJNUy9NaXJhdGkv5YaN6byO5Yy76I2vL0FycmF5PC90ZD4KICAgICAgICAgICAgPHRkPuaJueWHhuS4iuW4gjwvdGQ+CiAgICAgICAgICAgIDx0ZD7kuLTluopJSUnmnJ88L3RkPgogICAgICAgICAgICA8dGQ+MjAyMC8xMi8yMzwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD7ntKLmiZjmi4nopb/luIM8L3RkPgogICAgICAgICAgICA8dGQ+5a6J6L+b5Yi26I2vL+eZvua1juelnuW3njwvdGQ+CiAgICAgICAgICAgIDx0ZD7mibnlh4bkuIrluII8L3RkPgogICAgICAgICAgICA8dGQ+5Li05bqKSUlJ5pyfPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjMvNi8yNzwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD7ntKLnvo7mnaXmmJQ8L3RkPgogICAgICAgICAgICA8dGQ+5rWO5rCR5Y+v5L+hL+a1jueFnOWMu+iNry/msqrkuprnlJ/niak8L3RkPgogICAgICAgICAgICA8dGQ+55Sz6K+35LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPueUs+ivt+S4iuW4gjwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDI1LzYvNTwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD5EaXZhcmFzaWI8L3RkPgogICAgICAgICAgICA8dGQ+572X5rCPL+WfuuWboOazsOWFizwvdGQ+CiAgICAgICAgICAgIDx0ZD7kuLTluopJSUnmnJ88L3RkPgogICAgICAgICAgICA8dGQ+5Li05bqKSUkvSUlJ5pyfPC90ZD4KICAgICAgICAgICAgPHRkPjIwMTcvNS8zMTwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD5NSyAtIDEwODQ8L3RkPgogICAgICAgICAgICA8dGQ+TVNEL01lcmNrL+Wkp+m5j+iNr+WTgeW3peS4muagquW8j+S8muekvi9Bc3RleDwvdGQ+CiAgICAgICAgICAgIDx0ZD7kuLTluopJSUnmnJ88L3RkPgogICAgICAgICAgICA8dGQ+5Li05bqKSUlJ5pyfPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjQvNC8zPC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPkhKODkxPC90ZD4KICAgICAgICAgICAgPHRkPuivuuivmuWBpeWNjjwvdGQ+CiAgICAgICAgICAgIDx0ZD7kuLTluopJSUnmnJ88L3RkPgogICAgICAgICAgICA8dGQ+5Li05bqKSUlJ5pyfPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjQvMS84PC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPk9sb21vcmFzaWI8L3RkPgogICAgICAgICAgICA8dGQ+56S85p2lL0xveG88L3RkPgogICAgICAgICAgICA8dGQ+5Li05bqKSUlJ5pyfPC90ZD4KICAgICAgICAgICAgPHRkPuS4tOW6iklJSeacnzwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDIzLzExLzc8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+T3BudXJhc2liPC90ZD4KICAgICAgICAgICAgPHRkPuivuuWNjjwvdGQ+CiAgICAgICAgICAgIDx0ZD7kuLTluopJSUnmnJ88L3RkPgogICAgICAgICAgICA8dGQ+5Li05bqKSUlJ5pyfPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjEvMTEvMjQ8L3RkPgogICAgICAgIDwvdHI+CiAgICA8L3Rib2R5Pgo8L3RhYmxlPgoK5p2l5rqQ77yaaW5zaWdodO+8jOWbvemHkeivgeWIuOeglOeptuaJgApgYGA=
收藏
竞争格局
2025-09-24
原图定位
查看详情
格索雷塞与其他KRASG12C抑制剂的有效性和安全性对比
fCDlm74gNDLvvJrmoLzmo67pm7floZ7kuI7lhbbku5YgS1JBUyBHMTJDIOaKkeWItuWJgueahOacieaViOaAp+WSjOWuieWFqOaAp+WvueavlCB8ICB8CnwgLS0tIHwgLS0tIHwKfCB8IEdhcnNvcmFzaWIgfCBGdWx6ZXJhIHwgR2xlY2lyYXNpYiB8IFNvdG9yYXNpYiB8IEFkYWdyYXNpYiB8Cnwg5YWs5Y+4IHwg5q2j5aSn5aSp5pm077yb55uK5pa555Sf54mpIHwg5L+h6L6+55Sf54mp77yb5Yqy5pa55Yy76I2vIHwg6Im+5Yqb5pav77yb5Yqg56eR5oCdIHwgQW1nZW4gfCBCTVMgfAp8IOeglOeptiB8IEQxNTUzLTEwMiB8IE5DVDA1MDA1MjM0IHwgTkNUMDUwMDkzMjkgfCBDb2RlQnJlYWsgMTAwIHwgS1JZU1RBTC0xIHwKfCDkuLTluorpmLbmrrUgfCDljZXoh4LjgIFJSeacnyB8IOWNleiHguOAgUlJ5pyfIHwg5Y2V6IeC44CBSUnmnJ8gfCDljZXoh4LjgIFJSeacnyB8IOWNleiHguOAgUlJ5pyfIHwKfCDlhaXnu4TkurrnvqQgfCBLUkFTIEcxMkMg56qB5Y+Y55qE5ZCO57q/6Z2e5bCP57uG6IOe6IK655mM5oKj6ICFIHwgS1JBUyBHMTJDIOeqgeWPmOeahOWQjue6v+mdnuWwj+e7huiDnuiCuueZjOaCo+iAhSB8IEtSQVMgRzEyQyDnqoHlj5jnmoTlkI7nur/pnZ7lsI/nu4bog57ogrrnmYzmgqPogIUgfCBLUkFTIEcxMkMg56qB5Y+Y55qE5ZCO57q/6Z2e5bCP57uG6IOe6IK655mM5oKj6ICFIHwgS1JBUyBHMTJDIOeqgeWPmOeahOWQjue6v+mdnuWwj+e7huiDnuiCuueZjOaCo+iAhSB8Cnwg5YmC6YePIHwgNjAwbWcgQklEIHwgNjAwbWcgQklEIHwgODAwbWcgUUQgfCA5NjBtZyBRRCB8IDYwMG1nIEJJRCB8Cnwg5qC35pys6YePIHwgMTIzIHwgMTE2IHwgMTE5IHwgMTI0IHwgMTEyIHwKfCBPUlIgfCA1Mi4wJSB8IDQ5LjElIHwgNDcuOSUgfCA0MS4wJSB8IDQyLjklIHwKfCBEQ1IgfCA4OC42JSB8IDkwLjUlIHwgODYuMyUgfCA4NC4wJSB8IDc5LjUlIHwKfCBtRE9SICjmnIgpIHwgMTIuNSB8IE5FIHwgTkUgfCAxMi4zIHwgOC41IHwKfCBtUEZTICjmnIgpIHwgOS4xIHwgOS43IHwgOC4yIHwgNi44IHwgNi41IHwKfCBtT1MgKOaciCkgfCAxNC4xIHwgTkUgfCAxMy42IHwgMTIuNSB8IDEyLjYgfAp8IEdyYWRl4omlMyBUUkFFIHwgNTEuMiUgfCA0MS40JSB8IDM4LjclIHwgMjEuMCUgfCA0NC44JSB8CnwgVFJBRSDlr7zoh7TmsLjkuYXlgZzoja8gfCAwLjAlIHwgNy44JSB8IDUuMCUgfCA2LjAlIHwgNi45JSB8CgrotYTmlpnmnaXmupDvvJrljLvoja/prZTmlrnvvIzmi5vpk7blm73pmYXnjq/nkIPluILlnLo=
收藏
行业数据
2025-08-01
原图定位
查看详情
全球KRASG12C抑制剂临床研发布局(截至2025年6月)
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
收藏
行业数据
2025-08-01
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
全球已经获批上市五款 KRAS G12C抑制剂,中国已获批上市三款。中国获批的 KRAS G12C抑制剂分别为戈来雷塞、格索雷塞和氟泽雷塞。此外,济民可信/济煜医药/沪亚生物研发的索美来昔已正式提交国内上市申请,进入审批阶段。当前,KRAS G12C 抑制剂研发赛道竞争白热化,国内外多家制药企业正积极推进相关产品的临床开发进程。
竞争格局
原图定位
当前图表所属:
中国生物制药(1177.HK)-港股公司研究报告:传统Pharma龙头加速创新转型拓展全球布局-250922(46页).pdf
公司专利授权项目数持续增长
公司持续扩大创新研发投入(亿元)
可比公司盈利预测及估值情况
公司收入预测(百万元)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》